By Tina Reed – Axios –
Silicon Valley billionaires like Sam Altman, Peter Thiel and Jeff Bezos are pouring billions into ventures trying to slow or reverse the aging process, wagering that reprogrammable cells and AI-driven drug design can deliver a fountain of youth — or at least ward off death.
- Physician-researcher Eric Topol offers this dose of reality: The real game-changers are already here.
The big picture: In “Super Agers,” his new book due out Tuesday, the founder of the Scripps Research Translational Institute writes that the answer doesn’t lie in turning back time, but in harnessing our improved capabilities to predict and prevent chronic diseases.
The hunt for immortality is as old as life itself. But in the last decade, the once niche longevity field has exploded into the mainstream, drawing in scientists, biotechs, longevity clinics and wellness influencers.
